Report Detail
Global Insulin Delivery Systems Market Insights, Forecast to 2025
- RnM3430350 |
- 20 May, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Other
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries), a disposable reservoir for insulin (inside the pump) and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula.
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.
The global Insulin Delivery Systems market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Insulin Delivery Systems market based on company, product type, end user and key regions.
This report studies the global market size of Insulin Delivery Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Insulin Delivery Systems in these regions.
This research report categorizes the global Insulin Delivery Systems market by top players/brands, region, type and end user. This report also studies the global Insulin Delivery Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Market size by Product
Pens
Pumps
Pen Needles
Syringes
Market size by End User
Patients/Homecare
Hospitals & Clinics
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Insulin Delivery Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Insulin Delivery Systems market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Insulin Delivery Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Insulin Delivery Systems submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Insulin Delivery Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Insulin Delivery Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Insulin Delivery Systems Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Insulin Delivery Systems Market Size Growth Rate by Product
- 1.4.2 Pens
- 1.4.3 Pumps
- 1.4.4 Pen Needles
- 1.4.5 Syringes
- 1.5 Market by End User
- 1.5.1 Global Insulin Delivery Systems Market Size Growth Rate by End User
- 1.5.2 Patients/Homecare
- 1.5.3 Hospitals & Clinics
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Insulin Delivery Systems Market Size
- 2.1.1 Global Insulin Delivery Systems Revenue 2014-2025
- 2.1.2 Global Insulin Delivery Systems Sales 2014-2025
- 2.2 Insulin Delivery Systems Growth Rate by Regions
- 2.2.1 Global Insulin Delivery Systems Sales by Regions
- 2.2.2 Global Insulin Delivery Systems Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Insulin Delivery Systems Sales by Manufacturers
- 3.1.1 Insulin Delivery Systems Sales by Manufacturers
- 3.1.2 Insulin Delivery Systems Sales Market Share by Manufacturers
- 3.1.3 Global Insulin Delivery Systems Market Concentration Ratio (CR5 and HHI)
- 3.2 Insulin Delivery Systems Revenue by Manufacturers
- 3.2.1 Insulin Delivery Systems Revenue by Manufacturers (2014-2019)
- 3.2.2 Insulin Delivery Systems Revenue Share by Manufacturers (2014-2019)
- 3.3 Insulin Delivery Systems Price by Manufacturers
- 3.4 Insulin Delivery Systems Manufacturing Base Distribution, Product Types
- 3.4.1 Insulin Delivery Systems Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Insulin Delivery Systems Product Type
- 3.4.3 Date of International Manufacturers Enter into Insulin Delivery Systems Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Insulin Delivery Systems Sales by Product
- 4.2 Global Insulin Delivery Systems Revenue by Product
- 4.3 Insulin Delivery Systems Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Insulin Delivery Systems Breakdown Data by End User
6 North America
- 6.1 North America Insulin Delivery Systems by Countries
- 6.1.1 North America Insulin Delivery Systems Sales by Countries
- 6.1.2 North America Insulin Delivery Systems Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Insulin Delivery Systems by Product
- 6.3 North America Insulin Delivery Systems by End User
7 Europe
- 7.1 Europe Insulin Delivery Systems by Countries
- 7.1.1 Europe Insulin Delivery Systems Sales by Countries
- 7.1.2 Europe Insulin Delivery Systems Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Insulin Delivery Systems by Product
- 7.3 Europe Insulin Delivery Systems by End User
8 Asia Pacific
- 8.1 Asia Pacific Insulin Delivery Systems by Countries
- 8.1.1 Asia Pacific Insulin Delivery Systems Sales by Countries
- 8.1.2 Asia Pacific Insulin Delivery Systems Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Insulin Delivery Systems by Product
- 8.3 Asia Pacific Insulin Delivery Systems by End User
9 Central & South America
- 9.1 Central & South America Insulin Delivery Systems by Countries
- 9.1.1 Central & South America Insulin Delivery Systems Sales by Countries
- 9.1.2 Central & South America Insulin Delivery Systems Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Insulin Delivery Systems by Product
- 9.3 Central & South America Insulin Delivery Systems by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Insulin Delivery Systems by Countries
- 10.1.1 Middle East and Africa Insulin Delivery Systems Sales by Countries
- 10.1.2 Middle East and Africa Insulin Delivery Systems Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Insulin Delivery Systems by Product
- 10.3 Middle East and Africa Insulin Delivery Systems by End User
11 Company Profiles
- 11.1 Becton, Dickinson and Company
- 11.1.1 Becton, Dickinson and Company Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Becton, Dickinson and Company Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Becton, Dickinson and Company Insulin Delivery Systems Products Offered
- 11.1.5 Becton, Dickinson and Company Recent Development
- 11.2 Novo Nordisk
- 11.2.1 Novo Nordisk Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novo Nordisk Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novo Nordisk Insulin Delivery Systems Products Offered
- 11.2.5 Novo Nordisk Recent Development
- 11.3 Medtronic
- 11.3.1 Medtronic Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Medtronic Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Medtronic Insulin Delivery Systems Products Offered
- 11.3.5 Medtronic Recent Development
- 11.4 Sanofi
- 11.4.1 Sanofi Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Sanofi Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Sanofi Insulin Delivery Systems Products Offered
- 11.4.5 Sanofi Recent Development
- 11.5 ELI Lilly and Company
- 11.5.1 ELI Lilly and Company Company Details
- 11.5.2 Company Business Overview
- 11.5.3 ELI Lilly and Company Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 ELI Lilly and Company Insulin Delivery Systems Products Offered
- 11.5.5 ELI Lilly and Company Recent Development
- 11.6 Ypsomed Holding
- 11.6.1 Ypsomed Holding Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Ypsomed Holding Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Ypsomed Holding Insulin Delivery Systems Products Offered
- 11.6.5 Ypsomed Holding Recent Development
- 11.7 Animas Corporation
- 11.7.1 Animas Corporation Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Animas Corporation Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Animas Corporation Insulin Delivery Systems Products Offered
- 11.7.5 Animas Corporation Recent Development
- 11.8 Tandem Diabetes Care
- 11.8.1 Tandem Diabetes Care Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Tandem Diabetes Care Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Tandem Diabetes Care Insulin Delivery Systems Products Offered
- 11.8.5 Tandem Diabetes Care Recent Development
- 11.9 Insulet Corporation
- 11.9.1 Insulet Corporation Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Insulet Corporation Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Insulet Corporation Insulin Delivery Systems Products Offered
- 11.9.5 Insulet Corporation Recent Development
- 11.10 Biocon
- 11.10.1 Biocon Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Biocon Insulin Delivery Systems Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Biocon Insulin Delivery Systems Products Offered
- 11.10.5 Biocon Recent Development
12 Future Forecast
- 12.1 Insulin Delivery Systems Market Forecast by Regions
- 12.1.1 Global Insulin Delivery Systems Sales Forecast by Regions 2019-2025
- 12.1.2 Global Insulin Delivery Systems Revenue Forecast by Regions 2019-2025
- 12.2 Insulin Delivery Systems Market Forecast by Product
- 12.2.1 Global Insulin Delivery Systems Sales Forecast by Product 2019-2025
- 12.2.2 Global Insulin Delivery Systems Revenue Forecast by Product 2019-2025
- 12.3 Insulin Delivery Systems Market Forecast by End User
- 12.4 North America Insulin Delivery Systems Forecast
- 12.5 Europe Insulin Delivery Systems Forecast
- 12.6 Asia Pacific Insulin Delivery Systems Forecast
- 12.7 Central & South America Insulin Delivery Systems Forecast
- 12.8 Middle East and Africa Insulin Delivery Systems Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Insulin Delivery Systems Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Insulin Delivery Systems . Industry analysis & Market Report on Insulin Delivery Systems is a syndicated market report, published as Global Insulin Delivery Systems Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Insulin Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
